Avonex (interferon beta-1a) for multiple sclerosis

The FDA will soon approve Avonex (interferon beta-1a) for multiple sclerosis. It's also being considered by HPB.

Avonex is a beta-interferon...similar to Betaseron.

Beta-interferons help reduce the frequency of relapses in patients with the relapsing-remitting form of MS. They may also slow the progression of the disease.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote